Диссертация (1154746), страница 16
Текст из файла (страница 16)
The N domain of human angiotensin-Iconverting enzyme: the role of N-glycosylation and the crystal structure incomplex with an N domain-specific phosphinic inhibitor, RXP407 // J Biol. Chem.– 2010, - V 285, - N 46. – P. 35685-35693.84. Anton F.S., Marchionni M.A., Lee K.F., Rakis P. Role of GGF/neuregulinsignalling in interaction between migrating neurones and radial glia in the107developing cerebral cortex // Development.
– 1997, - V 124, - N 18. – P. 35013510.85. Anubhuti A.S. Role of neuropeptides in appetite regulation and obesity: areview // Neuropeptides. – 2006, - V. 40. – P. 375–40186. Ashmarin I.P., Karazeeva E.P. Search for evolutionary ancient, relict,regulatory peptides // Journal of Evolutionary Biochemistry and Physiology. –2007, - Т. 43, - № 1. - С. 123-125.87. Avital A., Goshen I., Kamsler A., Segal M., Iverfeldt K., Richter-Levin G.,Yirmiya R.
Impaired interleukin-1 signaling is associated with deficits inhippocampal memory processes and neural plasticity // Hippocampus. – 2003, - V13, - N 7. – P. 826-834.88. Azaryan A.V., Hook V.Y.H. Unique cleavage specificity of prohormone thiolprotease related to proenkephalin processing // FEBS Lett.
– 1994. – 341, N 2-3. –P. 197-202.89. Baraczka K., Pozsonyi T., Szuts I., Ormos G., Nekam K. Increased levels oftumor necrosis alpha and soluble vascular endothelial adhesion molecule-1 in thecerebrospinal fluid of patients with connective tissue diseases and multiplesclerosis // Acta Microbiol. Immunol.
Hung. – 2003, - V 50, - N 4. – P. 339-348.90. Baraniuk J.N., Whalen G., Cunningham J., Clauw D.J. Cerebrospinal fluidlevels of opioid peptides in fibromyalgia and chronic low back pain // BMCMusculoskelet Disord. – 2004, - V 5. – P. 48-55.91. Barnes K., Turner A.J., Kenny A.J.
Membrane localization of endopeptidase24.11 and peptidyl dipeptidase A (angiotensin converting enzyme) in the pig brain:astudyusingsubcellularfractionationandelectronmicroscopicimmunocytochemistry // J. Neurochem. – 1992. – 58, N 6. – P. 2088-2096.92. Barnes R.B., Namnoum A.B., Rosenfeld R.L., Layman L.C. The role of LHand FSH in ovarian androgen secretion and ovarian follicular development: clinicalstudies in a patient with isolated FSH deficiency and multicystic ovaries: casereport.
// Hum Reprod. – 2002, - V. 17. – P. 88-91.10893. Biber K., Zuurman M.W., Dijkstra I., Boddeke H. Chemokines in the brain:neuroimmunology and beyong // Curr. Opinion Pharmacol. – 2002. – V 2, - P. 6368.94. Binder D. BDNF and epilepsy: too much of a good thing? // Trends Neurosci. –2001. – V 24, - N 1. – P. 47-53.95. Birch N.P., Rodriguez C., Dixon J.E., Mezey E. Distribution ofcarboxypeptidase H messenger RNA in rat brain using in situ hybridizationhistochemistry: implications for neuropeptide biosynthesis // Brain Res.
Mol. BrainRes. – 1990. – 7, N 1. – P. 53-59.96. BiswasS.S.,HughesG.C.,ScarboroughJ.E.,DomkowskiP.W.Intramyocardial and intracoronary basic fibroblast growth factor in porcinehibernating myocardium: A comparative study // J Thorac. Cardiovasc. Surg. –2004, - V 127, - N 1.
– P. 34-43.97. Blackledge G., Averbuch S. Gefitinib ('Iressa', ZD1839) and new epidermalgrowth factor receptor inhibitors // Br J Cancer. – 2014, - V 90, - N 3, - P. 566-572.98. Bohley P. Intracellular proteolysis // Hydrolytic Enzymes. – Amsterdam, 1987.– P. 307-332.99. Bond J.S., Beynon R.J.U. Proteolysis and physiological regulation // Molec.Aspects Med. – 1987. – 9. – P.
173-287.100. Bonten E.J, Galjart N.J, Willemsen R, Usmany M, Vlak JM, d'Azzo A.Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalyticactivation // Biol Chem. – 1995. – 270. N 44. – P. 26441-26445.101. Brain S.D., Cox H.M. Neuropeptides and their receptors: innovative scienceproviding novel therapeutic targets // Br J Pharmacol.
– 2006, - V 147. – p. 202211.102. Briozzo P., Morisset M., Capony F., Rougeot C., Rochefort H., In vitrodegradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breastcancer cells // Cancer Res. 1988. N 48. p. 3688–3692.103. Brouillet J.P., Dufour F., Lemamy G., Garcia M., Schlup N., Grenier J., etal. Increased cathepsin D level in serum of patients with metastatic breast109carcinoma detected with a specific pro-cathepsin D immunoassay // Cancer. 1997.N 79.
p. 2132–2136.104. Bullet P, Stocklin R. Insect antimicrobial peptides: structures, properties andgene regulation // Protein Pept Lett. 2005, 12, р. 3–11105. Büning H., Hacker U.T. Inhibitors of Angiogenesis // Adv Exp Med Biol.2016. N 917. p. 261-285.106. Cain B.M., Wang W.G., Beinfeld M.C. Cholecystokinin (CCK) levels aregreatly reduced in the brains but not the duodena of Cpe(fat)/Cpe(fat) mice - aregional difference in the involvement of carboxypeptidase E (Cpe) in pro-CCKprocessing // Endocrinology. – 1997. – 138, N 9. – P.
4034-4037.107. Campenot R.B., MacInnis B.L. Retrograde transport of neurotrophins: Factand function // J Neurobiol. – 2004, - V 58, - N 2. – P. 217-229.108. Capony F., Rougeot C., Montcourrier P., Cavaille`s V., Salazar G.,Rochefort H. Increased secretion, altered processing, and glycosylation of procathepsin D in human mammary cancer cells // Cancer Res. 1989. N 49, p. 3904–3909.109.
Cavaill`es V., Augereau P., Rochefort H. Cathepsin D gene is controlled bya mixed promoter and estrogens stimulate only TATA dependent transcription inbreast cancer cells // Proc. Natl Acad. Sci. USA. 1993. N 90. p. 203–207.110. Chalazonitis A. Neurotrophin-3 in the development of the enteric nervoussystem // Prog. Brain Res. – 2004, - V 146.
– P. 243-263.111. Chaldakov G.N., Fiore M., Stankulov I.S., Manni L., Hristova M.G.,Antonelli A., Ghenev P.I., Aloe L. Neurotrophin presence in human coronaryatherosclerosis and metabolic syndrome: a role for NGF and BDNF incardiovascular disease? // Prog. Brain Res. 2004, - V 146. – P.
279-289.112. Changaris D.G., Lesousky N.W., Miller J.J., Levy R.S. Subcellularlocalization in rat brain of angiotensin-related carboxypeptidase activity distinctfrom converting enzyme // Pathol. Immunopathol. Res. – 1988. – 7, N 3. – P. 200207.110113. Chen T., Amons R., Clegg J.S., Warner A.H., MacRae T.H. Molecularcharacterization of artemin and ferritin from Artemia franciscana // Eur. JBiochem. – 2003, - V 270, - N 1, - P. 137-145.114.
Chesselet M.F., Hook V.Y. Carboxypeptidase H-like immunoreactivity inthe striatum of cats and monkeys // Regul. Pept. – 1988. – 20, N 2. – P. 151-159.115. Choi S.Y., Hwang J.J., Koh J.Y. NR2A induction and NMDA receptordependent neuronal death by neurotrophin-4/5 in cortical cell culture // JNeurochem. – 2004, - V 88, - N 3. – P. 708-716.116. Ciccocioppo R., Economidou D., Fedeli A., Angeletti S., Weiss F., HeiligM., Massi M. Attenuation of ethanol self-administration and of conditionedreinstatementofalcohol-seekingbehaviorbytheantiopioidpeptidenociceptin/orphanin FQ in alcohol-preferring rats // Psychopharmacology (Berl).
–2004, - V 172, - N 2. – P. 170-178.117. Correa F.M.A., Plunkett L.M., Saavedra J.M. Quantitative distribution ofangiotensin-converting (kininase II) in discrete areas of the rat brain byautoradiography with computerized microdensitometry // Brain Res. – 1986. – 375,N 2. – P. 259-266.118. Corry D.B., Kheradmand F. Biology and therapeutic potential of theinterleukin-4/interleukin-13 signaling pathway in asthma. // Am.
J Respir. Med. –2002, - V 1, - N 3. – P. 185-193.119. Croiset G., Nijsen M.J., Kamphuis P.J. Role of corticotropin-releasingfactor, vasopressin and the autonomic nervous system in learning and memory //Eur J Pharmacol. – 2000, - V 405. – P. 225-234.120. Das B., Sabban E.L., Kilbourne E.J., Fricker L.D. Regulation ofcarboxypeptidase E by membrane depolarization in PC12 pheochromocytomacells: comparison with mRNAs encoding other peptide- and catecholaminebiosynthetic enzymes // J. Neurochem.
– 1992. – 59, N 6. – P. 2263-2270.121. Dechant G., Neumann H. Neurotrophins // Adv. Exp. Med. Biol. – 2002, - V513. – P. 303-334.111122. Delcroix J., Valletta J., Wu C., Howe C.L., Lai C.F., Cooper J.D.,Belichenko P.V., Salehi A., Mobley W.C. Trafficking the NGF signal:implications for normal and degenerating neurons // Prog. Brain Res. – 2004.
– V146. – P. 3-23.123. Demmer W., Brand K. A dipeptidyl carboxypeptidase in brain synapticmembranes active in the metabolism of enkephalin containing peptides // Biochem.Biophys. Res. Commun. – 1983. – 114, N 2. – P. 804-812.124. Devi L. Tissue distribution of a dynorphin-processing endopeptidase //Endocrinology. – 1993. – 132, N 3. – P. 1139-1144.125. Dores R.M., Baron A.J. Evolution of POMC: origin, phylogeny,posttranslational processing, and the melanocortins // Ann. NY Acad.
Sci. – 2011, V 1220, - N 1. – P. 34-48.126. Du Z.Y., Shi M.H., Ji C.H., Yu Y. Serum pleiotrophin could be an earlyindicator for diagnosis and prognosis of non-small cell lung cancer // Asian Pac JCancer Prev. 2015. N 16(4). p. 1421-1425.127. Edwards C.R., Padfield P.L. Angiotensin-converting enzyme inhibitors:past, present and bright future // Lancet. – 1985. – 8419. – P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
